Allaying and alleviating amyloid agony and anxiety.

Morie A. Gertz

doi:10.1182/blood-2013-03-491746

Allaying and alleviating amyloid agony and anxiety.

Morie A. Gertz

Hematology

Research output: Contribution to journal › Comment/debate › peer-review

4 Scopus citations

Abstract

In this issue of Blood, Wechalekar and colleagues demonstrate the importance of treating all patients with amyloidosis, no matter how severe their situation is, because clinically important responses are seen. They also identify the adverse prognostic impact of a systolic blood pressure of < 100 mm Hg.

Original language	English (US)
Pages (from-to)	3301-3302
Number of pages	2
Journal	Unknown Journal
Volume	121
Issue number	17
DOIs	https://doi.org/10.1182/blood-2013-03-491746
State	Published - Apr 25 2013

ASJC Scopus subject areas

Biochemistry
Immunology
Hematology
Cell Biology

Access to Document

10.1182/blood-2013-03-491746

Cite this

@article{68ccf95a17c84c86bd65c1b5f13fcd15,

title = "Allaying and alleviating amyloid agony and anxiety.",

abstract = "In this issue of Blood, Wechalekar and colleagues demonstrate the importance of treating all patients with amyloidosis, no matter how severe their situation is, because clinically important responses are seen. They also identify the adverse prognostic impact of a systolic blood pressure of < 100 mm Hg.",

author = "Gertz, {Morie A.}",

year = "2013",

month = apr,

day = "25",

doi = "10.1182/blood-2013-03-491746",

language = "English (US)",

volume = "121",

pages = "3301--3302",

journal = "Unknown Journal",

issn = "1931-857X",

publisher = "American Physiological Society",

number = "17",

}

TY - JOUR

T1 - Allaying and alleviating amyloid agony and anxiety.

AU - Gertz, Morie A.

PY - 2013/4/25

Y1 - 2013/4/25

N2 - In this issue of Blood, Wechalekar and colleagues demonstrate the importance of treating all patients with amyloidosis, no matter how severe their situation is, because clinically important responses are seen. They also identify the adverse prognostic impact of a systolic blood pressure of < 100 mm Hg.

AB - In this issue of Blood, Wechalekar and colleagues demonstrate the importance of treating all patients with amyloidosis, no matter how severe their situation is, because clinically important responses are seen. They also identify the adverse prognostic impact of a systolic blood pressure of < 100 mm Hg.

UR - http://www.scopus.com/inward/record.url?scp=84879454197&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84879454197&partnerID=8YFLogxK

U2 - 10.1182/blood-2013-03-491746

DO - 10.1182/blood-2013-03-491746

M3 - Comment/debate

C2 - 23620568

AN - SCOPUS:84879454197

SN - 1931-857X

VL - 121

SP - 3301

EP - 3302

JO - Unknown Journal

JF - Unknown Journal

IS - 17

ER -

Allaying and alleviating amyloid agony and anxiety.

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this